TIL Q1 2026 Earnings WiderthanExpected Loss Highlights EarlyStage Development Challenges RXRX Q1 2026 Earnings EPS Beat Despite No Revenue Stock Slips 32 LGND Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Operational Strength NextDecade Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage BQ Q4 2022 Earnings NarrowerthanExpected Loss Lifts Sentiment